Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • 80 more Fixed Dose...

    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-18T10:59:08+05:30  |  Updated On 17 Aug 2021 1:01 PM IST

    According to the notification, some of the fixed dose combination drugs that have been banned include antibiotics like Cefglobe OZ, Taxim -OZ, drugs used for treating bacterial and fungal infections like Orflaz kit and Vaginobact, hypertension drugs like Telipril H and Loram H and anti-anxiety drug Resta (combination of Paracetamol+ Alprazolam).


    New Delhi: The Union Health Ministry has banned 80 more fixed-dose combination (FDC) drugs which include antibiotics, painkillers, medicines used for treating fungal and bacterial infections, hypertension and anxiety, officials said Thursday. A notification was issued by the government, stating that the ban has come into force since January 11, they said.


    With this, the total number of banned FDCs now stands at 405. Another 325 drugs were banned in September last year.


    The latter, however, remain available on account of the legal challenge mounted by affected pharma firms, the officials said.


    A fixed-dose combination contains two or more drugs combined in a fixed ratio of doses, available as a single dose.


    "Eighty new FDCs have been banned under the Drugs and Cosmetics Act, 1940 (23 of 1940), which prohibits the manufacture, sale and distribution of these drugs," a senior Health Ministry official said.


    According to the notification, some of the drugs that have been banned include antibiotics like Cefglobe OZ, Taxim -OZ, drugs used for treating bacterial and fungal infections like Orflaz kit and Vaginobact, hypertension drugs like Telipril H and Loram H and anti-anxiety drug Resta (combination of Paracetamol+ Alprazolam).


    These drugs were banned on the recommendation of the Drugs Technical Advisory Board (DTAB), which examined the rationality and safety of these FDCs.


    These FDCs are among over 294 drugs that were banned in 2007, but the pharma companies approached the court, sources said.


    Later, the matter reached the Supreme Court, which sends it to the DTAB to examine their efficacy, they said.


    On December 15, 2017, the DTAB submitted its recommendations and the apex court accepted their suggestions and recommended that certain FDCs, out of 294 FDCs, are not rational and are required to be prohibited or withdrawn, sources said.


    In September last year, the Health Ministry banned 325 FDCs, out of which the Supreme Court allowed the sale of three drugs, including Saridon. The ban on the other FDCs was challenged, they said.


    Also Read: No relief for Fixed Dose Combinations in Type 2 Diabetes: HC rejects pharma plea

    294 drugsantibioticsanxietyapex courtCefglobe OZDelhi high courtDrugs and Cosmetics ActDrugs and Cosmetics Act 1940Drugs Technical Advisory BoardDTABFDCFDCsFixed Dose Combinationfixed dose combinationsfungal and bacterial infectionsGovernment of IndiahypertensionIndian governmentLoram HmedicinesOrflaz kitpainkillersParacetamol+ AlprazolamRestaSaridonSupreme CourtTaxim -OZTelipril HVaginobact
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok